Analyst Ratings for Olema Pharmaceuticals (OLMA)
OLMA Rating Summary
OLMA Price Target Summary
- Highest: $62.00 (Citi)
- Lowest: $27.00 (Goldman Sachs)
- Average: $44.10
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.10 (+363.7%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
Avg. $ Target:
$44.10 (+363.7%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/26/2026 | Wolfe Research | Kalpit Patel | New Coverage | Peerperform (N/A) |
N/A (N/A) |
14.17 (9.51) |
-32.89% | Details |
| 3/19/2026 | Jefferies | Dennis Ding | New Coverage | Buy (N/A) |
40.00 (43.00) |
15.05 (9.51) |
-36.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
